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Abstract
Background
Schistosomiasis remains a major public health issue, with an estimated 230 million people
infected worldwide. Novel tools for early diagnosis and surveillance of schistosomiasis
are currently needed. Elevated levels of circulating microRNAs (miRNAs) are commonly
associated with the initiation and progression of human disease pathology. Hence, serum
miRNAs are emerging as promising biomarkers for the diagnosis of a variety of human
diseases. This study investigated circulating host miRNAs commonly associated with liver
diseases and schistosome parasite-derived miRNAs during the progression of hepatic
schistosomiasis japonica in two murine models.
Methodology/Principal Findings
Two mouse strains (C57BL/6 and BALB/c) were infected with a low dosage of Schistosoma
japonicum cercariae. The dynamic patterns of hepatopathology, the serum levels of liver
injury-related enzymes and the serum circulating miRNAs (both host and parasite-derived)
levels were then assessed in the progression of schistosomiasis japonica. For the first time,
an inverse correlation between the severity of hepatocyte necrosis and the level of liver
fibrosis was revealed during S. japonicum infection in BALB/c, but not in C57BL/6 mice.
The inconsistent levels of the host circulating miRNAs, miR-122, miR-21 and miR-34a in
serum were confirmed in the two murine models during infection, which limits their potential
value as individual diagnostic biomarkers for schistosomiasis. However, their serum levels
in combination may serve as a novel biomarker to mirror the hepatic immune responses
induced in the mammalian host during schistosome infection and the degree of hepato-
pathology. Further, two circulating parasite-specific miRNAs, sja-miR-277 and sja-miR-
3479-3p, were shown to have potential as diagnostic markers for schistosomiasis japonica.
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Conclusions/Significance
We provide the first evidence for the potential of utilizing circulating host miRNAs to indicate
different immune responses and the severity of hepatopathology outcomes induced in two
murine strains infected with S. japonicum. This study also establishes a basis for the early
and cell-free diagnosis of schistosomiasis by targeting circulating schistosome parasite-
derived miRNAs.
Author Summary
Schistosomiasis japonica remains a public health problem in Southeast Asia. In China, the
number of infected individuals has been reduced considerably due to long-term control
efforts over the past 50 years, but still 60 million people are at the risk of the disease. Devel-
opment of novel tools for early diagnosis and surveillance of schistosomiasis are urgently
needed. Circulating microRNAs are increasingly regarded as promising targets for the
next generation of diagnostic biomarkers. This study systematically compared both host-
and schistosome parasite-derived circulating miRNAs associated with Schistosoma japoni-
cum infection in two murine models. For the first time, we revealed that host circulating
miRNAs dysregulated after S. japonicum infection, are mouse strain-dependent, along
with different pathological responses. Three host circulating miRNAs, miR-122, miR-21
and miR-34a, may, as a panel, serve as indicative biomarkers for hepatopathology progres-
sions. We also confirmed previous reports of the value of parasite-specific miRNAs (sja-
miR-277 and sja-miR-3479-3p) in serum as potential biomarkers for the diagnosis of
schistosomiasis japonica. This study establishes a basis for using miRNAs as supplemental
biomarkers for the early and cell free diagnosis of schistosomiasis.
Introduction
Schistosomiasis is a chronic debilitating parasitic disease of humans. Caused by members of
the genus Schistosoma, it afflicts more than 200 million individuals worldwide, representing a
major health and economic burden in tropical and developing nations [1]. The pathology of
chronic Schistosoma japonicum or Schistosoma mansoni infection, in its severe form, results in
hepatosplenic schistosomiasis, with clinical symptoms of granuloma formation, periportal
fibrosis, portal hypertension, hepatosplenomegaly, ascites, and the formation of vascular
shunts [1]. The granuloma formation is characterised by a focussed accumulation of a group of
specific immune cells around the schistosome eggs, followed by a fibrosing lesion, which forms
as a zone of collagen at its periphery [2,3]. Both features, while beneficial in limiting and neu-
tralising the toxicity of secreted egg antigens (SEA) released from parasite eggs, also cause
reversible hepatic damage, indicating that the immune-cellular response is both friend and foe
to the schistosome-infected host [4,5].
The general epidemiological situation of schistosomiasis in China has changed due to long-
term extensive and integrated control efforts [6,7]. A number of endemic areas are close to
transmission interruption and thus improved diagnostic tools are urgently needed for the sur-
veillance of control efforts to ensure that the elimination of schistosomiasis can be achieved
[7]. Currently, there are four major methods available for the diagnosis of schistosomiasis:
parasitological detection (PD; mainly by the Kato-Katz method), antibody-detection (AbD),
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antigen-detection (AgD), and the detection of circulating schistosome nucleic acids (CNAD)
by PCR. The former three procedures have disadvantages in that they exhibit low sensitivity
(e.g. PD), cross-reactivity with other helminth infections or cannot distinguish between active
and past infections (e.g. AbD and AgD), with the latter limitation particularly important in
endemic areas. The requirement for the detection of schistosome ova in faeces and/or SEA-spe-
cific serum antibodies limits such methods for early diagnosis before patency. These inadequa-
cies demonstrate the current limitations in monitoring the progress of schistosomiasis control,
especially in areas with low schistosome prevalence or low levels of transmission [8].
MicroRNAs (miRNAs) are a class of small non-coding RNAs approximately 22 nucleotides
in length, which can be detected in a wide range of body fluids, including blood plasma/serum
[9,10]. The high stability of miRNAs in biofluids has been mainly attributed to two mecha-
nisms: (1) formation of a protein-miRNA complex with argonaute proteins or high-density
lipo-proteins, and (2) their incorporation into exosomes [11]. MiRNAs have been increasingly
regarded as promising targets for the next generation of diagnostic biomarkers as the strong
correlation between the status/progression of various diseases and the dysregulated profile of
miRNAs has been confirmed. The potential for detecting circulating miRNAs as biomarkers
for various cancers, viral infections, as well as drug-induced liver injury, has been widely
reported [9,12–17].
Previously, a panel of host miRNAs was shown to be dysregulated in murine hepatic tissue
with the progression of schistosomiasis, highlighting the fact that miRNAs may play a variety
of regulatory roles in the immunological responses that occur during the development of hepa-
topathology [18,19]. The altered expression profile of hepatic miRNAs during schistosomal
infection differed from that of other liver diseases [20], indicating that schistosome egg-
induced hepatic immunopathology is a unique type of chronic liver disease, distinguishable
from many other types of liver disease. Though the diagnostic and therapeutic potential of par-
asite-derived miRNAs have been discussed [21], the area is still in the early stages of infancy.
Nevertheless, five schistosome-specific miRNAs were identified in the plasma of rabbits
infected with S. japonicum using a deep sequencing method and one of them, sja-miR-3479-
3p, showed diagnostic potential for S. japonicum infection [22], although further confirmation
in other animal models and in patients is required. Further, the presence of three parasite-
derived miRNAs in serum discriminated patients infected with S.mansoni from normal indi-
viduals [18] and circulating parasite-derived miRNAs have been found in the plasma or serum
of dogs with a filarial worm infection [23]. Regarding host circulating miRNAs, inconsistent
results have been observed in different mouse models of schistosomiasis. For example, the level
of liver-specific miR-122 was elevated in the serum of BALB/c mice after S. japonicum infection
[24], while it did not change in the serum of C57BL/6 mice between 4–12 weeks post-S.man-
soni infection [18]. Since these two mouse strains induced differential pathological outcomes,
including the severity of hepatic granulomatous pathology and fibrosis at some particular time
points post-schistosome infection [25,26], these observations led us to suspect that hepato-
pathology progression of schistosomiasis may significantly affect the abundance of host miR-
NAs in serum.
Despite these recent studies, there is generally limited information about the diagnostic
value of circulating miRNAs in parasitic diseases and their associated pathologies. We
hypothesise that both host- and schistosome parasite-derived miRNAs in serum may present a
dysregulated profile during the progression of hepatic schistosomiasis, thereby providing
promising targets for an early and cell- diagnosis for the disease. In addition, circulating miR-
NAs of host origin may provide highly sensitive molecular signatures for the assessment of
hepatopathology severity induced by schistosome eggs. Two mouse strains, C57BL/6 and
BALB/c mice, were employed to verify our hypothesis.
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Materials and Methods
Ethics statement
All work was conducted with the approval of the QIMR Berghofer Medical Research Institute
Animal Ethics Committee (Ethics Approval: Project P288). Animal studies were conducted
according to the Australian Code for the Care and Use of Animals for Scientific Purposes (8th
edition) and the protocols approved by the QIMR Berghofer Medical Research Institute Ani-
mal Ethics Committee.
Mice and parasites
Eight-week-old female C57BL/6 and BALB/c mice were percutaneously infected with 14 S.
japonicum cercariae (Chinese mainland strain, Anhui population). Mice were euthanized at 4,
6, 7, 9, 11 (both mouse strains) and 13 (C57BL/6 only) weeks post infection (p.i.). Since BALB/
c mice are more susceptible to S. japonicum infection, the experiment with this strain lasted
for 11 weeks p.i. as prolonging the time of infection to 13 weeks would have resulted in prema-
ture death of many of the animals due to the resulting egg-induced pathology. Ten naive mice
were used as controls for each mouse strain. Each experimental group comprised 10 mice at
time points 4, 6 and 7 weeks p.i., and 12 mice were used at 9, 11 and 13 weeks p.i.. The liver
and blood samples (~1 mL) were collected by cardiac puncture at each time point. Eggs per
gram of liver were calculated as a measure of hepatic egg burden and general infection level,
as described [25]. Briefly, eggs were extracted from a portion of liver of known mass by over-
night digestion with 5% (w/v) potassium hydroxide. After centrifugation, eggs were then resus-
pended in 2 mL of 4% (v/v) formalin and the number of eggs in three 10 μL aliquots counted
and averaged to calculate the mean eggs per gram of liver (S1 Table).
Serum collection and RNA extraction
Blood samples were allowed to stand at room temperature for 2 h and then centrifuged at
4,000 rpm for 10 min at 4°C, followed by another centrifugation for 10 min at 10,000 rpm at
4°C. The supernatants were retained and stored at -80°C. Haemolysed samples were excluded
from further analysis (S1 Table). For each mouse, RNA was extracted from 100 μL of serum
using the miRNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s pro-
tocol. Non-parasitic miRNA (3.2 fmoles), ath-miR-159a, 50-UUUGGAUUGAAGGGAGCU
CUA-30 (IDT, Coralville, IA) was spiked to each denatured sample to normalize the technical
variability of the serum RNA extraction. For each sample, the final RNA product was eluted
into 30 μL nuclease-free water and stored at -80°C prior to further analysis. In some experi-
mental groups, blood samples from unisexually infected or uninfected mice without showing
any signs of hepatopathology were excluded from further analysis (S1 Table).
Polyadenylation and reverse transcription (RT)
Polyadenylation and RT reactions were performed with S-Poly(T) method with minor modifi-
cations to a published protocol [27]. Total RNA was polyadenylated with a Poly(A) polymerase
tailing kit (Epicentre Biotechnologies, Madison, WI) and the first-strand cDNA was synthe-
sized using a TaqMan microRNA reverse transcription kit (Life Technologies, Carlsbad,
CA) in a 10 μL RT reaction: 2.53 μL H2O, 1 μL 10 × PAP buffer, 0.1 μL ATP (10 mM), 0.5 μL
miRNA-specific primer pool (50 nM for each primer), 0.04 μL dNTPs (25 mM each), 0.13 μL
RNase inhibitor, 0.2 μL Poly(A) polymerase, 0.5 μL MultiScribe MuLV and 5 μL RNA. Reverse
transcription (RT) reactions were conducted using a Veriti 96-well thermal cycler (ABI) under
the following conditions: 42°C for 60 min, 95°C for 5 min. RT products were stored undiluted
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at -20°C prior to the further qRT-PCR reactions. A list of all the primers used in this study is
presented in S2 Table. The efficiency of PCR amplification for each primer pair was evaluated
by creating a standard curve plot for 10-fold serial dilutions of PCR product (S2 Table).
Quantification of miRNAs
Quantification of serum miRNAs was performed according to qPCR protocols described previ-
ously [28]. Briefly, the 10 μL PCR reaction contained 3 μL H2O, 0.5 μL of RT products (2.5×
dilution), 0.5 μL forward primer, 0.5 μL universal reverse primer (final conc: 0.2 μM), 0.5 μL
universal double-quenched probe (56-FAM/CAGAGCCAC/ZEN/CTGGGCAATTT/3IABkF
Q, final conc: 0.25 μM) (IDT) and 5 μL TaqMan Universal Master Mix II (Life Technologies).
Amplification was performed on an Applied Biosystems Viia 7 thermal cycler (Applied Biosys-
tems) with the cycling conditions: pre-denaturation at 95°C for 10 min, followed by 40 cycles:
95°C for 15 sec, and 60°C for 30 sec. For detecting parasite-derived miRNAs, 50 cycles were
performed, and the maximum cycle value of 42 was set as background for the purpose of calcu-
lating signal over noise. Spiked-in ath-miR-159a was used as the normalized internal control,
and the fold change was calculated by the 2-ΔΔCt method [29]. A comparative analysis was car-
ried out to highlight any concordance with respect to host miRNAs between the two mouse
strains based on the log base2-transformed qPCR data. The sequences of the primers used are
listed in S2 Table. The PCR products were further examined by 15% TBE-PAGE (S1 Fig).
Three technical replicates were performed for each sample and repeated PCR assays were car-
ried out for detection of each miRNA (S2 Fig). A biological replicate was carried out with
serum samples from BALB/c mice at 4 and 9 weeks post-infection (S3 Fig).
Histological assessment and biochemical analyses
The median lobe from each mouse liver was used for histological assessment. Formalin-fixed,
paraffin embedded liver sections were stained with Haematoxylin and Eosin (H&E) as a mea-
sure of granuloma and necrosis, picosirius red for collagen as a measure of fibrosis, alpha-
smooth muscle actin (α-SMA) and immunoperoxidase staining for myofibroblasts/Hepatic
Stellate Cells (HSCs). Slides were digitised using the Aperio Slide Scanner (Aperio Technolo-
gies, Vista, USA). Granuloma volume density and percent of hepatic necrosis, percent of colla-
gen staining (degree of fibrosis) and percent of positive α-SMA staining were quantified with
an Aperio ImageScope V10.2.1 with H&E, picosirius red, and α-SMA stained slides, respec-
tively; myofibroblasts/HSCs were defined as α-SMA positive, spindle-shaped cells associated
with focal areas of inflammation [25]. Serum alanine transaminase (ALT) and aspartate trans-
aminase (AST) levels were measured with the ALT and AST colour endpoint assay kits (Bioo
Scientific, Austin, TX), respectively, according to the manufacturer’s instructions.
Statistical analyses
All results are reported as means ± SEM (standard error of the mean). For analysis of the
serum levels of host miRNAs as well as that of ALT and AST levels during the infection course,
one-way ANOVA followed by Holm-Sidak multiple comparison was used. For analysis of rela-
tive serum abundance of host miRNAs, hepatic egg burden and histology, two-way ANOVA
followed by Holm-Sidak multiple comparisons were used to compare statistical differences
between the two mouse strains. For analysis of the parasite-derived miRNAs in serum, the
Man-Whitney test was used and p-values of<0.05 were considered statistically significant.
Associations were measured using Spearman’s Rho correlation in GraphPad Prism Version
6.00 for windows.
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Results
Temporal abundance analysis of host serummiRNAs in two murine
models during S. japonicum infection
Two mouse strains, C57BL/6 and BALB/c, were employed as schistosomiasis japonica disease
models to detect in serum, four host circulating miRNAs, miR-122, miR-21, miR-20a and
miR-34a, all of which have been suggested to be correlated with different types of liver disease
progression [30–33]. In C57BL/6 mice, the serum concentrations of miR-122, miR-20a and
miR-34a did not change at any time point post infection, but the level of serum miR-21 was
increased at 6 (1-Way ANOVA, P<0.01) (Fig 1A). In contrast, apart from miR-20a, the serum
levels of the three other host miRNAs were significantly elevated in BALB/c mice by 6 (miR-
122) or 7 (miR-21 and miR-34a) weeks p.i. and thereafter (Fig 1B and S3 Fig). Similar results
were observed by He et al., who found that the levels of miR-122 and miR-34a were signifi-
cantly elevated in the serum of BALB/c mice at 72 days post-S. japonicum infection [24]. There
was a tendency, albeit not statistically significantly, for relatively high expression of miRNA-
20a in the serum of infected BALB/c mice at 7 weeks p.i. and thereafter. This may have been
due to the existence of multiple relatively high expressed miRNA-20a isomiRs and the design
of the RT-primer against this miRNA, since we only designed one RT-primer against one form
Fig 1. Temporal dysregulation of serum host miRNAs in C57BL/6 and BALB/c mice at different p.i. time points.MiRNAs were quantified by qRT-PCR,
normalised to spiked ath-miR-159a, and fold changes were defined as the ratio of serummiRNA abundance in infected mice to naive mice (A, C57BL/6; B,
BALB/c). Statistical significance between infected and naive mice was determined using 1-Way ANOVA. Comparisons of relative serum abundance of
miRNAs between C57BL/6 and BALB/c mice at 4–11 weeks p.i. were determined using 2-Way ANOVA (C). (* = P<0.05, ** = P<0.01, *** = P<0.001, **** =
P<0.0001, ns = no significant difference).
doi:10.1371/journal.pntd.0003965.g001
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of miRNA-20a isomiRs. Thus, the low efficiency of reverse transcription of other miRNA-20a
isomiRs might have impaired the sensitivity of detecting this miRNA to some degree. Another
explanation is that the expression of miRNA-20a may be down-regulated in the necrotic hepa-
tocytes. Accordingly, we carried out comparative analysis of the relative abundance of these
miRNAs in the two mouse strains. With miR-122 and miR-34a, there was a significant differ-
ence between the two mouse strains at 4–11 weeks p.i., while for miR-21 and miR-20a, signifi-
cant difference was only observed at 7 weeks p.i. (Fig 1C). In light of these differing results
between the two strains, we carried out further parasitological, histological and serum chemis-
try analyses.
Parasitological, histological and serum biochemistry analyses
There were no significant differences in hepatic egg burden between the two mouse strains at
any time-point (2-Way ANOVA, P>0.05) (Fig 2A), indicating that differences in hepatic egg
burden did not cause the differential serum levels of miR-122, miR-21 and miR-34a observed
in the two mouse strains during S. japonicum infection.
Granuloma area was significantly greater in infected C57BL/6 mice compared with BALB/c
mice at 9 and 11 weeks p.i.. In C57BL/6 mice, the granuloma area represented 38.8% and
37.5% of the total liver area at 9 and 11 weeks p.i., respectively, whereas the granuloma area in
BALB/c mice was 19.9% and 17.9% of the total liver area at the corresponding time points,
respectively (2-Way ANOVA, P<0.0001) (Fig 2B). These differences are likely due to the
hepatic granuloma area being continually increased in size in C57BL/6 mice between 7~9
weeks p.i., while it had plateaued by this time in BALB/c mice. Although not statistically signifi-
cant, granuloma area also showed a tendency towards increased size in C57BL/6 mice com-
pared with BALB/c mice at 6 weeks p.i. (Fig 3A and 3B).
Hepatic fibrosis was induced more rapidly in C57BL/6 mice compared with BALB/c mice.
This was reflected by significantly greater collagen deposition in C57BL/6 mice at 6 weeks p.i.,
where collagen represented 17.1% of the total liver area, compared with 6.2% in BALB/c mice
(2-Way ANOVA, P<0.01) (Figs 2C, 3C and 3D). However, at 7 weeks p.i. there was no signifi-
cant difference in hepatic fibrosis between the two mouse strains (2-Way ANOVA, P>0.05).
Similar to the granuloma area, hepatic fibrosis in C57BL/6 mice was significantly more inten-
sive than those in BALB/c mice at 9 and 11 weeks p.i. (2-Way ANOVA, P<0.0001). The differ-
ential activation level of myofibroblasts/Hepatic Stellate Cells (HSCs) in the two mouse strains
showed a similar pattern with hepatic fibrosis (Figs 2D, 3E and 3F).
In contrast, H&E staining indicated that hepatic necrosis was significantly more pro-
nounced in BALB/c mice than in C57BL/6 mice at 6 and 11 weeks p.i. (2-Way ANOVA,
P<0.001 and P<0.05, respectively) (Fig 2E). It is noteworthy that, on average, the necrosis area
represented 0.73% of the total liver area in C57BL/6 mice, whereas it reached 2.39% in BALB/c
mice at 6 weeks p.i. (Figs 2E, 3A and 3B). Followed the development of granulomas and liver
fibrosis, the severity of hepatic necrosis was alleviated in BALB/c mice and no significant differ-
ences were observed between the two mouse strains at 7 and 9 weeks p.i.. Based on the analysis
of data from 6–13 weeks p.i., a significant inverse correlation was observed between the level of
hepatic necrosis and the degree of granuloma formation in C57BL/6 mice (r = -0.4393,
P = 0.0073), but not in BALB/c mice (Fig 2F). More importantly, significant inverse correla-
tions were observed between the level of hepatic necrosis and fibrosis in both mouse strains
(C57BL/6, r = -0.4908, P = 0.0024; BALB/c, r = -0.3484, P = 0.0373) (Fig 2G). These observa-
tions led us to hypothesise that the up-regulation of serum miR-122, miR-21 and miR-34a lev-
els in BALB/c mice during infection may be mainly due to the massive release of these miRNAs
from necrotic hepatocytes.
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In order to test this hypothesis, we further examined the dynamic changes in serum levels of
the liver injury-related enzymes, aspartate aminotransferase (AST) and alanine aminotransfer-
ase (ALT). Similar to the temporal alteration of the serum level of miR-21 in C57BL/6 mice,
the serum AST level was only significantly elevated at 6 weeks p.i. (1-Way ANOVA, P<0.05)
(Fig 4A), whereas the serum ALT level was significantly up-regulated at 6, 7 and 11 weeks p.i.
(1-Way ANOVA, P<0.001, P<0.05, and P<0.01, respectively). In BALB/c mice, both serum
AST and ALT levels were significantly elevated at 6 weeks p.i. and thereafter (1-Way ANOVA,
P<0.0001, except for AST level at 11 weeks p.i., P<0.001). Further analysis revealed that the
Fig 2. Parasitological and histological comparisons between C57BL/6 and BALB/c mice during S. japonicum infection. Hepatic egg burdens (A) did
not differ significantly between strains; Granuloma area (B), Hepatic fibrosis (C), and myofibroblasts/Hepatic Stellate Cells (HSCs) numbers (D) were
significantly increased in C57BL/6 mice compared with BALB/c mice at particular time points p.i.; Hepatic necrosis (E) was significantly more extensive in
BALB/c mice compared with C57BL/6 mice at 6 and 11 weeks p.i.. Statistical significance between strains was determined using 2-Way ANOVA. (* =
P<0.05, ** = P<0.01, *** = P<0.001, **** = P<0.0001, ns = no significant difference). Correlations between the severity of liver necrosis and the level of
hepatic granuloma (F), as well as the level of hepatic fibrosis (G) in both mouse strains were performed using Spearman’s Rho correlation.
doi:10.1371/journal.pntd.0003965.g002
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serum levels of all four miRNAs were significantly correlated with ALT and AST levels in
BALB/c mice (Fig 4B and 4C), whereas only the serum level of miR-21 showed a significant
correlation with the serum levels of these liver enzymes in C57BL/6 mice (Fig 4B and 4C).
Moreover, as shown in Fig 4D, the serum levels of all four miRNAs were significantly positively
correlated with the severity of liver necrosis in BALB/c, but not in C57BL/6 mice, an observa-
tion which provided additional direct evidence in support of our hypothesis. The reason why
serum miRNA levels did not correlate with the severity of liver necrosis in C57BL/6 mice is
largely because the degree of hepatic necrosis in this strain is not as pronounced as in BALB/c
mice during the course of S. japonicum infection. Further, the abundance of serum miRNAs in
C57BL/6 mice are at baseline levels post-infection. Among these four miRNAs, the serum con-
centration of miR-122 showed the strongest association with the serum levels of liver injury-
related enzymes and the severity of hepatic necrosis in BALB/c mice during S. japonicum infec-
tion, and this was followed by miR-21 (Fig 4B–4D). In addition, the abundance of serum miR-
34a showed the strongest association with the degree of liver fibrosis in BALB/c mice during
schistosomiasis progression, followed by miR-122 and miR-21 (Fig 4E).
Fig 3. Histological staining demonstrating differences in hepatopathology between C57BL/6 and BALB/c mice.Granulomatous pathology was more
severe in C57BL/6 mice; in contrast, hepatic necrosis (pink) was more intensive in BALB/c mice (A and B; Haematoxylin and Eosin). Collagen deposition
(red) was also greater in the C57BL/6 mice (C and D; Sirius Red), as was the activation of myofibroblasts/HSCs (brown) (E and F; α-SMA staining). All
images were derived frommice at 6 weeks p.i. and were taken frommurine livers with similar egg burdens. A, C and E (C57BL/6); B, D and F (BALB/c) were
taken from liver sections of the samemouse. Scale bar = 1 mm.
doi:10.1371/journal.pntd.0003965.g003
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Detection of parasite-derived miRNAs in the serum of C57BL/6 and
BALB/c mice during S. japonicum infection
Using a deep sequencing method, Cheng et al. identified the presence of five schistosome-spe-
cific miRNAs (sja-bantam, sja-miR-3479-3p, sja-miR-10-5p, sja-miR-3096 and sja-miR-8185)
in the plasma of S. japonicum-infected rabbits. Three of these (sja-bantam, sja-miR-3479-3p,
sja-miR-10-5p) were further detected in the plasma of S. japonicum-infected mice by stem-
Fig 4. Temporal changes in serumAST and ALT activities in C57BL/6 and BALB/c mice at different p.i. time points and correlation analysis
between the serum levels of miRNAs, liver enzymes and the severity of hepatopathology. Serum AST and ALT activities were more dramatically up-
regulated in BALB/c mice than in C57BL/6 mice during S. japonicum infection (A). Statistical significance between infected and naive mice was determined
using 1-Way ANOVA. (* = P<0.05, ** = P<0.01, *** = P<0.001, **** = P<0.0001, ns = no significant difference). Correlations between the serum levels of
miRNAs and AST level (B); ALT level (C), the severity of liver necrosis (D) and hepatic fibrosis (E) in both mouse strains were performed using Spearman’s
Rho correlation.
doi:10.1371/journal.pntd.0003965.g004
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loop RT-PCR analysis [22]. More recently, it was shown that S.mansoni-derived miRNAs
(miR-277, miR-3479-3p and bantam) in serum could discriminate infected from uninfected
individuals [18]. We thus carried out RT-qPCR analysis to determine the dynamic serum levels
of five parasite-derived miRNAs (sja-bantam, sja-miR-3479-3p, sja-miR-3096, sja-miR-8185
and sja-miR-277) during S. japonicum infection. Sja-miR-10-5p was excluded from analysis
due to its high sequence homology with mammalian host orthologs. Only two parasite-derived
miRNAs (sja-miR-277 and sja-miR-3479-3p) could be reliably detected in serum specimens
from both mouse strains (Figs 5A–5D and S3 Fig). However, one intriguing feature was the
time phase when the serum levels of these two miRNAs started to significantly alter differed in
the two models. In BALB/c mice, sja-miR-277 and sja-miR-3479-3p showed a statistically sig-
nificant signal over noise as early as 4 and 6 weeks p.i. (Fig 5C and 5D), respectively, while in
C57BL/6 mice, these signals were delayed to 6 and 9 weeks p.i. (Fig 5A and 5B), respectively.
Moreover, both the serum levels of sja-miR-277 and sja-miR-3479-3p were significantly corre-
lated with hepatic egg burdens (Fig 5E and 5F) and the degree of liver fibrosis (Fig 5G and 5H)
in the two mouse strains. However, the serum level of sja-miR-277 showed a stronger correla-
tion with liver fibrosis intensity than that of sja-miR-3479-3p. All key results obtained with the
two mouse strains are summarized in Table 1.
Discussion
The recent discovery of the extreme stability of circulating miRNA in body fluids and the fact
their dysregulated profiles are associated with disease progression are characteristic of a wide
variety of diseases and syndromes. These features of miRNAs have trigged widespread interest
in their potential as biomarkers for diagnosis and pathologic status of chronic and infectious
diseases. This study aimed to investigate whether several circulating host miRNAs commonly
Fig 5. Temporal serum levels of parasite-derivedmiRNAs in C57BL/6 and BALB/c mice at different time points and their correlations with hepatic
egg burdens. The serum levels of sja-miR-277 and sja-miR-3479-3p in C57BL/6 (A and B) and BALB/c (C and D) mice, respectively, during the course of
infection. MiRNAs were quantified by qRT-PCR and normalised to the spiked ath-miR-159a; fold changes are defined as the ratio of miRNA abundance in the
serum of infected mice compared with the background level in the serum of naive mice. Statistical differences between infected and naive mice were
determined using the Man-Whitney test (ns = no significant difference, ** = P<0.01, *** = P<0.001, **** = P<0.0001). Correlations between the serum level
of sja-miR-277/sja-miR3479-3p and hepatic egg burden (E and F), as well as the degree of hepatic fibrosis (G and H) were performed for both mouse strains.
doi:10.1371/journal.pntd.0003965.g005
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associated with liver diseases are dysregulated in murine schistosomiasis japonica and whether
S. japonicum-derived miRNAs could be detected in serum specimens from two mouse strains
during disease progression, thus determining their potential value as biomarkers for evaluation
of the severity of hepatopathology caused by schistosome eggs and the detection of S. japoni-
cum infection, respectively.
The advantage of using two mouse strains in this study was the capacity to observe the con-
siderably different dysregulation of circulating host miRNAs, miR-122, miR-21 and miR-34a,
in the sera of C57BL/6 and BALB/c mice during S. japonicum infection. We also assessed the
fibrogenic granulomatous response induced by schistosome eggs which leads to the hepato-
pathology characteristic of schistosomiasis, an area of considerable interest [5,34–37]. In con-
trast, hepatic necrosis is another type of hepatopathology caused by the toxicity due to
schistosome eggs, an area which has received much less attention. The key differences in hepa-
topathology observed between the two mouse strains examined here is centrally linked to the
delayed development of fibrosis, with the level of hepatic necrosis in BALB/c mice markedly
more extensive than in C57BL/6 mice at 6 weeks p.i.. The different degree of leakage of egg
antigens into the adjacent liver tissue at 6 weeks p.i. in the two mouse strains may contribute
partially to the intensity of fibrosis latter as soluble egg antigen (SEA) of schistosomes has been
shown to suppress the activation and facilitate apoptosis of HSCs [37,38]. For the first time, we
have shown an inverse correlation between the severity of hepatocyte necrosis and the level of
liver fibrosis in both mouse models, which further supports the protective role of fibrosis in
restricting the SEA within focal areas of chronic inflammation, thus reduce the hepatotoxic
effects caused by the eggs trapped in the liver tissue [39]. Also this may explain the differential
serum levels of hepatocellular enzymes, as well as different abundances in some serum host
miRNAs observed between the two mouse strains. Thus, as summarized in Table 1, the differ-
ential levels of miR-122, miR-21 and miR-34a in host sera are mainly the result of hepato-
pathology caused by the different types of immune response induced in C57BL/6 and BALB/c




Changes in serum AST level + ++++
Changes in serum ALT level ++ ++++
Hepatic histology
Hepatic granuloma +++ +
Hepatic ﬁbrosis +++ +
Hepatic necrosis + ++
Host circulating miRNAs
Changes in serum mmu-miR-122 level - +++
Changes in serum mmu-miR-21 level + +++
Changes in serum mmu-miR-20a level - -
Changes of serum mmu-miR-34a level - +++
Parasite-derived miRNAs
Changes in serum sja-miR-277 level ++, 6 weeks p.i.* +++, 4 weeks p.i.*
Changes in serum sja-miR-3479-3p level +, 9 weeks p.i.* ++, 6 weeks p.i.*
* The time point when the circulating miRNA started to show a signiﬁcantly different level in the S.
japonicum-infected mice compared with naïve mice.
doi:10.1371/journal.pntd.0003965.t001
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mice after S. japonicum infection, especially following the onset of egg deposition. These three
host circulating miRNAs may, as a panel, serve as indicative biomarkers for the severity of
hepatopathology outcomes, particularly regarding hepatocytes damage or necrosis, in patients
having similar worm burdens. However, further studies with clinical samples are needed to jus-
tify this suggestion.
It is well known that circulating miRNAs are derived either via passive release of cellular
contents from tissue damage or via active secretion of microvesicles/exosomes from cells [40].
Here, significant correlations between the levels of serum miRNAs (miR-122 and miR-21) and
liver enzymes indicate that the passive release from injured tissues may represent a key mecha-
nism for the observed increased levels of these miRNAs. MiR-122 is the predominant liver-spe-
cific miRNA, constituting about 70% of the total miRNA population in normal liver tissue
[41]. This may explain why the significant alteration in miR-122 serum levels could be sensi-
tively detected in BALB/c mice as early as 6 weeks p.i., at the same time when hepatic necrosis
is evident. There are consistent observations that miR-122 serum levels are elevated in a num-
ber of liver diseases with different etiologies, suggesting that this miRNA may act as a clear bio-
marker of general liver injury [11,42]. Furthermore, plasma miR-122 has been shown to have a
better performance than ALTs in the detection of liver injury [43,44]. The serum miR-20a and
miR-34a levels showed a significant but weaker correlation with the serum AST and ALT levels
than those of miR-122 and miR-21 in BALB/c mice. These data indicate that other tissues,
such as the spleen and/or intestine, which also retain schistosome eggs, may contribute to the
serum levels of miR-20a and miR-34a, both are multi-tissue expressed miRNAs [45,46]. It
would be useful to investigate the pathology of other injured organs during schistosomiasis for
the complete recognition of potential sources of these new biomarkers.
In BALB/c mice, the elevated serum miR-122 and miR-21 levels showed a much stronger
correlation with hepatocellular enzymes than with the level of hepatic necrosis. This can be
explained by the fact that hepatic necrosis peaked at 6 weeks p.i. in this strain and dramatically
decreased thereafter, while the serum levels of miR-122 and miR-21 reached a plateau after 7
weeks p.i., due to accumulation of these miRNAs, which are extremely stable in body fluids
[9,47]. Meanwhile, the degree of hepatic granuloma and fibrosis also stabilized after 7 weeks p.
i. in BALB/c mice, which resulted in significant positive correlations between the serum miR-
122 and miR-21 levels and hepatic fibrosis severity. However, no positive correlation in the
serum levels of these four miRNAs and the degree of liver fibrosis was observed in C57BL/6
mice. Hence, it could be misinterpreted that the elevation in serum levels of miR-122 and miR-
21 was caused by the fibrogenic granulomatous responses, rather than actually being caused by
necrosis, if only the results from BALB/c mice were considered. Previously, He et al. showed
that circulating miR-223 could serve as a potential novel biomarker for the detection of S. japo-
nicum infection [24]. However, miR-21, miR-122 and miR-223 were also shown elevated in the
serum of patients with HCC (hepatic cellular carcinoma) and chronic hepatitis and these miR-
NAs were suggested as novel biomarkers for liver injury but not specifically for HCC [32],
thereby providing support that the elevation of serum miRNA-223 level might also be caused
by liver necrosis due to S. japonicum infection.
Three circulating S.mansoni-derived miRNAs, sma-miR-277, sma-miR-3479-3p and sma-
bantam, have been shown to have potent diagnostic value in detecting S.mansoni infection
[18], but in the current study, only two orthologs, sja-miR-277 and sja-miR-3479-3p, could be
reliably detected in the sera of the two mouse strains infected with S. japonicum. This may be
due to two reasons: (1) mice were challenged with a low dose of cercariae compared with the
previous study [18]; (2) the serum level of sja-bantam was comparatively lower than that of sja-
miR-277 and sja-miR-3479-3p. We detected significant increases in the serum level of sja-miR-
277 in BALB/c and C57BL/6 mice at 4 and 6 weeks p.i., respectively, earlier than with S.
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mansoni—8 weeks p.i.-, although a higher challenge was given in their study. This could have a
technical explanation that, unlike Hoy et al., who employed the miScript system to perform the
reverse transcription reactions [18], here, we employed the S-Poly(T) method, which has been
shown to improve both the specificity and sensitivity of the PCR reaction [27]. As miRNAs
usually have different isoforms, known as isomiRs [48,49], the design of multiple RT primers
against different isomiRs originated from one particular miRNA may further improve the sen-
sitivity of miRNA detection when using the S-Poly(T) method.
We found that schistosome egg-induced pathology may also impact on the detection of par-
asite-derived miRNAs in serum. This was reflected by the differential time phase for detecting
sja-miR-277 and sja-miR-3479-3p in serum. Hepatic granulomas and more importantly, fibro-
sis, tightly enclose most schistosome eggs trapped in the liver, so as to limit the release of the
parasite-derived hepatotoxic proteins and miRNAs from eggs into the surrounding tissue. This
may have delayed the detection of these miRNAs in the serum of C57BL/6 mice, when com-
pared with BALB/c mice. The significant correlation between the serum level of these parasite
miRNAs and the hepatic egg burden indicates that eggs might serve as an important source for
these miRNAs, since a single adult worm pair of S. japonicum can release an estimated number
of 3,000 eggs per day. It is also notable that sja-miR-277 and sja-miR-3479-3p are not the most
highly expressed miRNAs in either adult worms or eggs, but are observed at intermediate levels
[50]. The most highly expressed miRNAs in the parasite, such as sja-miR-71, sja-miR-71b-5p
and sja-miR-1 [50], are undetectable in the serum/plasma of animal hosts infected with schis-
tosomes [18,22]. This observation suggests that schistosome parasite-derived miRNAs, which
may be expressed in a cell- or tissue-specific pattern, are selectively released by adult worms
and eggs. Exosomes display significantly different selective enrichment of specific extra-cellular
miRNAs compared to those from their source cells [51]. However, it does not exclude the fact
that adult worms secrete miRNAs into the circulating blood stream, since we have also detected
sja-miR-277 and sja-miR-3479-3p in the serum of mice infected with unisexual male worm(s)
(S4 Fig). Thus, adult worms and/or eggs contribute to the origin of these parasite-derived miR-
NAs in serum, which may represent potential markers for the early diagnosis of
schistosomiasis.
In summary, inconsistent serum levels of host miR-122, miR-21 and miR-34a in different
murine models during infection may impair their value as diagnostic biomarkers for schistoso-
miasis. However, the serum levels of these miRNAs as a panel may correlate with the hepatic
immune responses of a schistosome-infected individual, and they may serve as novel biomark-
ers to indicate the degree of hepatopathology caused by schistosomiasis. The circulating para-
site-specific miRNAs, sja-miR-277 and sja-miR-3479-3p, have potential to be diagnostic
markers for schistosomiasis japonica, but the sensitivity for early detection of these miRNAs
may not only depend on the parasite load but may also be affected by the host pathology
induced by schistosome eggs.
Supporting Information
S1 Fig. The specificity of the PCR products was validated by 15% TBE-PAGE gels.M, Ultra
low range DNA ladder; lane 1, ath-miR-159a; lane 2, mmu-miR-122; lane 3, mmu-miR-21;
lane 4, mmu-miR-20a; lane 5, mmu-miR-34a; lane 6, ath-miR-159a; lane 7, sja-miR-277; lane
8, sja-miR-3479-3p.
(TIF)
S2 Fig. Pearson correlation scatter plots of the levels of serum miRNAs in C57BL/6 (A) and
BALB/c (B) mice between the two replicate qRT-PCR assays. Pearson correlation values vary
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between 0.7375 and 0.9335.
(TIF)
S3 Fig. Data obtained from the repeat experiment with BALB/c mice at 4 and 9 weeks p.i.
(A) Hepatic egg burdens; (B) Serum AST and ALT levels. Statistical significance between
infected and naive mice was determined using 1-Way ANOVA (ns = no significant difference,
 = P<0.001,  = P<0.0001). (C) Serum levels of host miRNAs (mmu-miR-122, mmu-
miR-21, mmu-miR-20a and mmu-miR-34a); fold changes are defined as the ratio of serum
miRNA abundance in infected mice compared with naive mice. Statistical significance between
infected and naive mice was determined using 1-Way ANOVA (ns = no significant difference,
 = P<0.05,  = P<0.01); (D) Serum levels of parasite-derived miRNAs (sja-miR-277 and sja-
miR-3479-3p); fold changes are defined as the ratio of miRNA abundance in the serum of
infected mice compared with the background level in the serum of naive mice. Statistical signif-
icance between infected and naïve mice was determined using the Man-Whitney test (ns = no
significant difference,  = P<0.05,  = P<0.001).
(TIF)
S4 Fig. The serum levels of parasite-derived miRNAs, sja-miR-227 (A) and sja-miR-3479-
3p (B) in C57BL/6 mice infected with unisexual male worm(s). Fold changes are defined as
the ratio of miRNA abundance in infected mice serum compared with the background abun-
dance level in naive mice serum. Statistical significance between infected and naïve mice was
determined using the Man-Whitney test ( = P<0.01).
(TIF)
S1 Table. Hepatic egg burden values for each mouse and reasons for sample exclusion.
(XLSX)
S2 Table. Sequences of oligonucleotide primers and probe used in this study.
(XLSX)
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